There is no consensus on which drugs/techniques/strategies can affect mortality in the perioperative period of cardiac surgery. With the aim of identifying these measures, and suggesting measures for prioritized future investigation we performed the first international consensus conference on this topic. methods: The consensus was a continuous international internet-based process with a final meeting on June 28th 2010 in Milan at the Vita-Salute University. Participants included 340 cardiac anesthesiologists, cardiac surgeons and cardiologists from 65 countries all over the world. A comprehensive literature review was performed to identify topics that subsequently generated position statements for discussion, voting and ranking. results: of the 17 major topics with a documented mortality effect, seven were subsequently excluded after further evaluation due to concerns about clinical applicability and/or study methodology. The following topics are documented as reducing mortality: administration of insulin, levosimendan, volatile anesthetics, statins, chronic beta-blockade, early aspirin therapy, the use of preoperative intra-aortic balloon counterpulsation and referral to high-volume centers. The following are documented as increasing mortality: administration of aprotinin and aged red blood cell transfusion. These interventions were classified according to the level of evidence and effect on mortality and a position statement was generated. conclusion: This international consensus conference has identified the non-surgical interventions that merit urgent study to achieve further reductions in mortality after cardiac surgery: insulin, intra-aortic balloon counterpulsation, levosimendan, volatile anesthetics, statins, chronic beta-blockade, early aspirin therapy, and referral to high-volume centers. The use of aprotinin and aged red blood cells may result in increased mortality.
introduction Every year over one million patients worldwide undergo cardiac surgery (1) and are exposed to significant morbidity and mortality.
hSr proceedings in intensive care and cardiovascular Anesthesia 2011, vol. 3 Many drugs, techniques and management strategies have been used in an attempt to reduce this mortality. Currently no consensus exists as to their effect either positive or negative on patient mortality. The goal of this first International Consensus Conference was to identify these ancillary (i.e. non-surgical) interventions; to quantify their impact either positive or negative on all-cause mortality in cardiac surgery; and then to make suggestions to both researchers and donors as to which topics deserve further investigation in the immediate future.
mEthodS
Cardiac anaesthesiologists, cardiac surgeons, and cardiologists participated in person, through email or through the congress website. In the period May 2008 -June 2010 a core group of experts in the field undertook a comprehensive review of the published evidence related to the prevention of perioperative mortality in cardiac anesthesia and intensive care. Each participant suggested one or more topics of interest and submitted them electronically together with one or more articles published in peer-reviewed journals supporting their opinion. over 100 international anesthesiology and cardiac surgery scientific societies were contacted and asked to disseminate information about the Consensus Conference (either via email or by means of website links) to allow their authoritative representatives to participate. All journals with an impact factor in the fields of Anesthesiology, Critical Care Medicine, Cardiac and Cardiovascular Systems were contacted and asked to suggest seminal papers to be included in the Consensus Conference. over 50 patient and nurse associations were contacted via email and asked to disseminate information about the conference to their members. e) the drug/technique/strategy was used in the operative room or in an intensive care unit; f) mortality was the endpoint, or mortality was included in a composite endpoint. The Consensus was a continuous interactive web-based process, with the main, final meeting held on June 28 th 2010 at the VitaSalute University of Milan, Italy when all 120 suggested topics were discussed. Major and minor topics where identified according to the presence or not of at least one article showing a statistically significant reduction/increase in mortality. After a presentation from both a rapporteur and a co-rapporteur a short statement was drawn up for each major topic describing the reasons for it being considered as providing convincing (Table 1) , or non convincing ( Table 2) evidence. Thus, for each convincing major topic the Consensus Conference approved a position statement, and highlighted the appropriate peer-reviewed published evidence. final statements were created, discussed and corrected during the conference and later on exposed to the judgment of all the web participants: from June 29 th to September 30 th 2010 participants were asked to support or challenge the findings and statements from the meeting via a web questionnaire and were asked again to disclose any potential conflict of interest. The Consensus Conference decided not to address echocardiography and the drugs/ techniques/strategies already addressed in the guidelines for the management of Sepsis and ARDS, and for peri-operative blood conservation and transfusions.
rESultS
Three-hundred-forty participants from 65 countries ( Figure 1 and Figure 2 ) suggested 120 topics: 17 of them were supported by an article with a significant effect on mortality (2-20) while 103 topics were not (Figure 3 A meta-analysis of RCTs 12 suggested a reduction in perioperative all cause mortality in patients receiving alfa-2 adrenergic agonists (clonidine, dexmedetomidine, or mivazerol). The Consensus Conference decided not to include this intervention as the majority of this evidence comes from patients undergoing vascular surgery and not from a cardiac surgery specific setting.
Epidural analgesia (38%)
A meta-analysis of RCTs 13 suggested a reduction in the composite endpoint of mortality (longest follow up available, up to 13 years) and/or myocardial infarction in patients receiving perioperative epidural analgesia. The Consensus Conference decided not to include this technique due to safety issues (underreporting of rare complications) and the use of a composite end-point to achieve statistical significance.
fenoldopam (34%)
Two meta-analyses of RCTs 14, 15 suggested that fenoldopam can reduce all cause in hospital mortality in patients with or at risk for acute renal failure. The Consensus Conference decided that the evidence comes from critically ill patients 14 and from cardiovascular patients 15 and not from a cardiac surgery specific setting.
nesiritide (24%)
A single underpowered RCT) 16 suggested a reduction in 180-day mortality in cardiac surgery with the use of nesiritide, but a recent meta-analysis did not confirm this finding 17 .
norepinephrine vs dopamine (48%)
A recent RCT 18 suggested a 28-day mortality reduction in patients with cardiogenic shock when compared to dopamine. The Consensus Conference decided that the evidence comes from patients with cardiogenic shock and not from a cardiac surgery specific setting. furthermore, the dosage of dopamine reported in the study was much higher than generally used.
off-pump coronary artery bypass grafting (11%)
A recent meta-analysis of RCTs 19 suggested an increase in long term mortality in patients operated with the off-pump techniques. The Consensus Conference decided that, since this was a specific surgical decision, this topic was not among the core topics of the Consensus Conference. furthermore, this article 19 focused on late (≥1year mortality).
Pexelizumab (32%)
A subgroup analysis of a meta-analysis of RCTs 20 suggested that pexelizumab might reduce mortality (longest follow up available, up to 6 months) in patients undergoing CABG. This topic was not included among the most important topics as it was the only topic that did not receive a sufficient percentage of votes from the audience (32% at the first round and 35% at the second round).
peer reviewed published article to support their effect on mortality were either eliminated (if not deemed of potential value) or grouped and summarized as minor topics in table 3 (if considered of potential value). The Consensus Conference stated that these minor topics might be beneficial/detrimental in terms of survival in the perioperative setting, but acknowledged that there is still no evidence base to support them.
figure 1
The 65 countries that participated in the consensus conference.
figure 2 Most European countries participated in the consensus conference diScuSSion
This is the first consensus statement of its kind examining non-surgical interventions aimed at reducing mortality in cardiac surgery. It was hoped that its creation would provide a starting point for researchers and donors as well as serve as a guide for clinicians. The findings contained in this document provide then, for the first time, a comprehensive review of these non-surgical interventions. The majority of the interventions described as potentially having an impact on mortality (Table 1 ) are cheap and simple to perform which hold the promise that their worldwide adoption or in some cases avoidance, could have a significant impact on cardiac mortality worldwide. To realise the potential life saving effects of these interventions it is imperative that steps be taken to validate these findings. This should be in the form of an RCT large enough to detect a reduction in mortality. It is sobering to realise that no randomized clinical trial of more than 10,000 patients has ever been conducted in the field of perioperative cardiac surgery.
It is reasonable to assume that these findings may, at least in part, be applicable to non-cardiac surgery and general intensive care settings. As these populations are much larger their use may result in even greater mortality reductions. The Consensus Conference identified seven other interventions with a potential effect on mortality ( Table 2) . These were excluded for a wide range of reasons ranging from concerns regarding study endpoints to the exclusion of studies conducted in populations other than cardiac surgery. Their exclusion does not reflect a rejection of the intervention in its entirety and there is value in further investigating these interventions. Systematic reviews with meta-analysis have become popular in the anesthesia and surgical literature and currently dominate the evidence based hierarchy (21 with a similar clarity to that of randomized trials. To gain maximal benefit from systematic reviews it would be beneficial if researchers adopt a standardised manner of randomized study reporting. This would significantly improve the ability to compare various studies with each other. furthermore, researchers, reviewers and editorial boards of peer reviewed journal should understand the importance of reporting clinically relevant outcomes with the intention to treat analysis even when publishing small RCTs focusing on surrogate endpoints. The manner in which this conference has been conducted is a reflection of how use can be made of current electronic resources to maximise participation and more importantly to ensure that all relevant clinical information is identified and evaluated. With the ever increasing proliferation of clinical evidence this consensus conference may serve as a model on how to synthesis and disseminate clinically relevant information. In a field such as cardiac surgery where patients are still faced with a high risk of perioperative morbidity and mortality it is imperative to foster the dissemination of results that may impact on patient outcome. It is interesting to note that the two interventions that received the highest percentage of support (beta-blockers -94% and the use of early aspirin -87%) received this support without there being any RCTs or meta-analysis of RCTs regarding their use in cardiac surgery. This suggests that clinicians and scientists are not fully aware or do not completely agree with the evidence based hierarchy. It may in addition reflect a tendency to extrapolate findings from one aspect of medicine and apply it to another without consideration to the levels of support for these actions. finally all 17 of the papers described in table 1 and 2 were published in the last decade, suggesting that scientific awareness and investigation into this field is rapidly increasing.
Limitations of the present work -In general there is a dearth of evidence based medicine in this sector of cardiac surgery. only two out of ten major papers described large RCTs, and three papers were meta-analysis of small RCTs. The other five papers were either nonRCTs or meta-analysis including nonRCTs, testifying the paucity of large RCTs in this specific setting.
concluSionS
By conducting a comprehensive updated International Consensus Congress we have identified all the ten ancillary drugs/techniques/strategies that might reduce mortality in cardiac surgery. We thus suggest that future research and funding be directed toward these topics.
Endorsements
The Consensus Conference was endorsed by the Italian Ministry of Health, the Italian Association of Cardiothoracic Anesthesiologists (ITACTA), the Italian Society for Cardiac Surgery (SICCH), the Metaanalysis and Evidence-based Medicine Training in Cardiology (METCARDIo), EXPo Milano 2015, the SIAARTI (Società Italiana Analgesia Anestesia Rianimazione Terapia Intensiva) study group of cardiothoracic and vascular anesthesia, the Colombian Cardiovascular Committee of the Colombian Anesthesia Society, and the Italian Critical Care nurses Association (AISACE). 
